Medication info
Arva Tablet 40 mg (Atorvastatin Calcium Trihydrate)

Arva Tablet 40 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›43.38mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle
Approval status
Active

MFDS item code 202002626 · Approved 2020.04.14 · Insurance code 656005090

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who uses it
Adults
Adult dosage
Patients receiving atorvastatin must follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may begin treatment with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It decreases the risk of myocardial infarction and stroke in adults aged 55 and over, or those with multiple risk factors such as smoking, hypertension, and low HDL cholesterol. It is also effective for vascular interventions and chronic stable angina. In patients with type 2 diabetes who have risk factors for coronary artery disease, it can lower the risks of myocardial infarction and stroke. Additionally, in patients already diagnosed with coronary heart disease, it effectively reduces the risk of myocardial infarction, stroke, vascular interventions, hospitalization due to congestive heart failure, and angina, thereby alleviating symptoms and preventing complications. Furthermore, it is used to lower total cholesterol, LDL-cholesterol, apo-B protein, and triglyceride levels, while increasing HDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. As an adjunct for hyperlipidemia treatment, it also improves blood lipid levels.

Dosage and Administration

Adult dosage

Patients receiving atorvastatin must follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may begin treatment with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Precautions

This medication may cause muscle problems, so if there is severe muscle pain or weakness, or if there is a significant increase in creatine kinase levels, use should be discontinued immediately. Patients with poor liver function or liver disease should not take this medication and should undergo regular liver function tests. This medication should not be used by pregnant or nursing women, and women of childbearing age should use appropriate contraceptive methods while taking it. When taken with certain medications, drug levels may increase and the risk of side effects may rise, so patients should inform their doctor or pharmacist if they are taking other medications. Elderly patients or those with decreased kidney function have a higher risk of myopathy, so caution is needed during use, and if symptoms occur, medical consultation is required immediately. If symptoms such as muscle pain, malaise, or fever occur during treatment, the physician should be informed immediately and tests should be conducted. This medication has not been sufficiently proven safe and effective for use in children, so it should not be used in children under 10 years of age. There is no specific antidote for overdose, so treatment should be based on symptoms, and regular assessments of liver function and muscle-related tests should be conducted. Medications should be kept out of reach of children and stored in the original container to maintain quality.

Side effects

  • Weakness
  • fatigue
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 168 more
  • anorexia
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased CK in blood
  • positive leukocytes in urine
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • anxiety disorders
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • increased tension
  • myositis
  • muscle diseases
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • contracture
  • increased myoglobin in blood
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • skin ulcers
  • erectile dysfunction
  • urinary tract infections
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • pigmentation urine
  • hypoglycemia
  • increased appetite
  • vascular neurogenic edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • retinal hemorrhage
  • auditory loss
  • glaucoma
  • taste alterations
  • taste disorders
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • increased potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to store the medication at room temperature in a cool place, specifically between 1°C and 30°C.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.